0seguidores
2018fundada en
Acerca de Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Sede251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Fundado2018
EstadoActivo
Patentes1 patente
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Reseñas
Aún no hay reseñas. ¿Has trabajado con Assertio Therapeutics, Inc.? Sé el primero en compartir tu experiencia.
Información legal
| Razón social | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Ver en GLEIF ↗ |
| Domicilio social | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Estado | Activo |
Fuentes: GLEIF · actualizado 16 de Octubre de 2026
Contacto y enlaces
Ubicación
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
¿Es tu empresa?
Reclama esta página gratis para añadir tu logo, productos, fotos y empleos, y para responder a las reseñas.
Reclamar esta páginaÚnase a Heelky para conectar, contratar y crecer
Cree una cuenta gratuita para enviar mensajes, postularse a empleos y publicar misiones.
Únase ahora: es gratis